81
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Using Thromboelastography to Predict Blood Loss After Off-Pump Coronary Artery Bypass Grafting

, , , , , , & show all
Pages 949-956 | Published online: 19 Mar 2021

References

  • Roffi M, Gencer B, Storey RF, Andreotti F, Patrono C. Clinical perspectives and pearls from the 2015 ESC NSTE-ACS Guidelines. Curr Cardiol Rep. 2016;18(5):48. doi:10.1007/s11886-016-0722-0
  • Barbieri L, Pergolini P, Verdoia M, et al. Novara Atherosclerosis Study Group (NAS). Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor. Vascul Pharmacol. 2016;79:11–15. doi:10.1016/j.vph.2015.10.006
  • Stone GW, Clayton TC, Mehran R, et al. Impact of major bleeding and blood transfusions after cardiac surgery: analysis from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial. Am Heart J. 2012;163(3):522–529. doi:10.1016/j.ahj.2011.11.016
  • Kozek-Langenecker SA, Ahmed AB, Afshari A, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: first update 2016. Eur J Anaesthesiol. 2017;34(6):332–395.
  • Gorlinger K, Dirkmann D, Solomon C, Hanke AA. Fast interpretation of thromboelastometry in non-cardiac surgery: reliability in patients with hypo-, normo-, and hypercoagulability. Br J Anaesth. 2013;110(2):222–230. doi:10.1093/bja/aes374
  • Ak K, Isbir CS, Tetik S, et al. Thromboelastography-based transfusion algorithm reduces blood product use after elective CABG: a prospective randomized study. J Card Surg. 2009;24(4):404–410. doi:10.1111/j.1540-8191.2009.00840.x
  • Mace H, Lightfoot N, McCluskey S, et al. Validity of thromboelastometry for rapid assessment of fibrinogen levels in heparinized samples during cardiac surgery: a Retrospective, Single-center, Observational Study. J Cardiothorac Vasc Anesth. 2016;30(1):90–95. doi:10.1053/j.jvca.2015.04.030
  • Pagano D, Milojevic M, Meesters MI, et al. 2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery. Eur J Cardiothorac Surg. 2018;53(1):79–111.
  • Nakayama Y, Nakajima Y, Tanaka KA, et al. Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. Br J Anaesth. 2015;114(1):91–102. doi:10.1093/bja/aeu339
  • Schöchl H, Voelckel W, Maegele M, Kirchmair L, Schlimp CJ. Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concentrate: a 7-day observational study of trauma patients. Crit Care. 2014;18(4):R147. doi:10.1186/cc13982
  • Singh SK, Devenraj V, Tewarson V, Kumar S, Kaushal D, Chandra T. Thromboelastography in off-pump coronary artery bypass grafting. Asian Cardiovasc Thorac Ann. 2015;23(4):430–434. doi:10.1177/0218492314558636
  • Rafiq S, Johansson PI, Kofoed KF, et al. Thrombelastographic hypercoagulability and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): a randomized controlled trial. Platelets. 2017;28(8):786–793. doi:10.1080/09537104.2017.1280147
  • Pillai RC, Fraser JF, Ziegenfuss M, Bhaskar B. The influence of circulating levels of fibrinogen and perioperative coagulation parameters on predicting postoperative blood loss in cardiac surgery: a Prospective Observational Study. J Card Surg. 2014;29(2):189–195. doi:10.1111/jocs.12255
  • Boer C, Meesters MI, Milojevic M. Task force on patient blood management for adult cardiac surgery of the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Cardiothoracic Anaesthesiology (EACTA). 2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery. J Cardiothorac Vasc Anesth. 2018;32(1):88–120. doi:10.1053/j.jvca.2017.06.026
  • Yang Z, Xie Z, Pei X, Quan X, Feng D. Effect of thrombelastography on timing of coronary artery bypass grafting. Exp Ther Med. 2018;16(2):579–584. doi:10.3892/etm.2018.6202
  • van Diepen S, Fuster V, Verma S, et al. Dual antiplatelet therapy versus aspirin monotherapy in diabetics with multivessel disease undergoing CABG: FREEDOM Insights. J Am Coll Cardiol. 2017;69(2):119–127. doi:10.1016/j.jacc.2016.10.043
  • Levine GN, Bates ER, Bittl JA, et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Thorac Cardiovasc Surg. 2016;152(5):1243–1275. doi:10.1016/j.jtcvs.2016.07.044
  • Valgimigli M, Bueno H, Byrne RA; ESC Scientific Document Group; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018;39(3):213–260. doi:10.1093/eurheartj/ehx419
  • Levi M, Levy JH, Andersen HF, Truloff D. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med. 2010;363(19):1791–1800. doi:10.1056/NEJMoa1006221
  • Weber CF, Görlinger K, Meininger D, et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology. 2012;117(3):531–547. doi:10.1097/ALN.0b013e318264c644